ADO 8.70% 2.1¢ anteotech ltd

Saliva Clinical Trial, page-5

  1. 295 Posts.
    lightbulb Created with Sketch. 182
    What makes you suspect this?

    The CE mark updated approval is scheduled for June. This will be a quicker process than the original approval. I suspect the trials are complete or very close too and the data is being collated, then the board must type up an announcement that the entire board must approve.
 
watchlist Created with Sketch. Add ADO (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.